Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXeros Tech Regulatory News (XSG)

Share Price Information for Xeros Tech (XSG)

Share Price is delayed by 15 minutes
Get Live Data
1.45    0.00 (0.00%)
Bid:
1.35
Ask:
1.55
Spread: 0.20 (14.815%)
Market Cap: £12.50m
XSG Live PriceLast checked at - London Stock Exchange

Intraday Xeros Tech Share Chart

Symphony Project Development Agreement

18 Sep 2017 07:00

RNS Number : 9616Q
Xeros Technology Group plc
18 September 2017
 

18 September 2017

 

Xeros Technology Group plc

 

First Symphony Project development agreement signed with major OEM

 

Xeros Technology Group plc (AIM: XSG, 'Xeros'), the developer and provider of polymer based technologies with multiple commercial applications, has signed its first Symphony Project development agreement with a leading manufacturer of commercial washing machines ('the OEM').

 

The OEM is a leader in commercial laundry machines with a significant presence in many major markets across the world. Under the terms of the development agreement, Xeros will incorporate its 'open source' technology in the OEM's machine for the purposes of technical validation and testing. Following the testing phase the parties anticipate the commencement of commercial negotiations.

 

In April 2017, Xeros announced Symphony Project, providing 'open source' access to its innovative polymer technology to manufacturers of commercial washing machines, which it subsequently launched at the Clean Show in Las Vegas in June to demonstrate its first fully working prototype to the industry.

 

Symphony Project will enable manufacturers to sell their own-branded products as well as receiving a share in the long-term savings that the Xeros technology delivers.

 

The development of the Symphony Project is in line with Xeros' strategy to commercialise its technology with partners, who already have strong market positions. It will enable the Group to make a financial return on its intellectual property and know-how with relatively low capital intensity.

 

A website providing a full explanation of Symphony Project is available here: www.symphonyproject.com

 

Mark Nichols, Chief Executive of Xeros, said:

 

"This represents a significant milestone for our Cleaning Technologies business. The scale and market presence of our OEM partner demonstrates the industry's increasing understanding and acceptance of our technology.

 

"With a proven technology, and growing demand for the sustainability, performance and economic benefits our technology delivers, Symphony Project will enable us to significantly accelerate the commercialisation of our technology."

 

Enquiries:

 

Xeros Technology Group plc

Mark Nichols, Chief Executive Officer

Paul Denney, Chief Financial Officer

Tel: 0114 321 6328

 

Jefferies International Limited (Nominated Adviser and Joint Broker)

Simon Hardy / Will Soutar

 

Tel: 020 7029 8000

Berenberg (Joint Broker)

Chris Bowman / Ben Wright / Amritha Murali

 

Tel: 020 3207 7800

Instinctif Partners

Adrian Duffield / Helen Tarbet / James Gray

 

Tel: 020 7457 2020

Notes to Editors

Xeros Technology Group plc (LN: XSG) is a platform technology company that is reinventing water intensive industrial and commercial processes by reducing water and chemistry usage with its polymer technologies. Its patented technologies have the capacity to provide material economic, operational and sustainability improvements that are unattainable with traditional processes. The Group is currently exploiting its intellectual property in three areas: Cleaning Technologies, Tanning Technologies and Textile Technologies. Xeros has a number of agreements in place with such international organisations as BASF, Hilton and Wollsdorf Leder.

 

For more information, please visit - http://www.xerostech.com/

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRBDGDCUBBBGRR
Date   Source Headline
11th Aug 20157:00 amRNSUpdate on joint development programme
29th Jul 20154:43 pmRNSBlocklisting Interim Review
2nd Jun 20159:10 amRNSOpening of Manufacturing Partner's New Facility
29th May 201511:34 amRNSTotal Voting Rights
28th Apr 20157:01 amRNSCo-development programme with LANXESS
28th Apr 20157:00 amRNSInterim Results
23rd Apr 20157:00 amRNSNorth American Partners Sign Up
3rd Mar 20157:00 amRNSNotice of Results
10th Feb 20157:00 amRNSFURTHER INCENTIVE PROGRAMMES FROM US UTILITIES
3rd Feb 20151:13 pmRNSHolding(s) in Company
2nd Feb 20153:30 pmRNSTotal Voting Rights
30th Jan 20156:15 pmRNSDirector Shareholding
28th Jan 20154:40 pmRNSSecond Price Monitoring Extn
28th Jan 20154:35 pmRNSPrice Monitoring Extension
23rd Jan 20157:00 amRNSXeros adds US patent
21st Jan 20155:45 pmRNSApplication for Block Listing
20th Jan 20154:35 pmRNSPrice Monitoring Extension
22nd Dec 20142:09 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
9th Dec 201411:00 amRNSResult of AGM
3rd Nov 20143:45 pmRNSNotice of AGM & Posting of Annual Report
28th Oct 201410:45 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
22nd Oct 20147:01 amRNSFINAL RESULTS FOR THE YEAR ENDED 31 JULY 2014
22nd Oct 20147:00 amRNSNew Director Appointment
20th Oct 20147:00 amRNSFURTHER INCENTIVE PROGRAMMES FROM US
30th Sep 20142:15 pmRNSHolding(s) in Company
29th Sep 20147:00 amRNSNotice of Full Year Results & Capital Markets Day
22nd Sep 20147:00 amRNSUpdate on Contract Wins
3rd Jul 20147:00 amRNSAWARD OF CIP ECO-INNOVATION GRANT
18th Jun 20144:08 pmRNSBoard Change
29th May 20143:17 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
29th May 20147:00 amRNSFIRST INCENTIVE PAYMENT BY A UTILITY
22nd May 201412:09 pmRNSISSUE OF SHARES
15th May 20147:00 amRNSDirector Share Purchase
1st May 20142:30 pmRNSDirector / Senior Executive Share Purchases
30th Apr 20147:00 amRNSInterim Results
25th Apr 20147:00 amRNSNotice of Results
28th Mar 201411:22 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
27th Mar 20143:30 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
25th Mar 20147:01 amRNSAdmission and First Day of Dealings on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.